TelyRx Holdings Inc.
TELYF
$1.78
-$0.10-5.32%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | 142.67% | 179.82% | 205.53% | 327.77% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 142.67% | 179.82% | 205.53% | 327.77% | |
| Cost of Revenue | 126.96% | 152.57% | 91.35% | 211.65% | |
| Gross Profit | 155.80% | 206.64% | 299.49% | 618.08% | |
| SG&A Expenses | 201.90% | 307.61% | 307.95% | 716.73% | |
| Depreciation & Amortization | 79.53% | 85.29% | 156.13% | 188.89% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 169.36% | 225.35% | 213.79% | 352.18% | |
| Operating Income | -396.45% | -3,623.17% | -264.11% | -1,655.56% | |
| Income Before Tax | -263.63% | -12,205.26% | -159.52% | 83.33% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -263.63% | -12,205.26% | -159.87% | 83.33% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -263.63% | -12,205.26% | -247.03% | 84.80% | |
| EBIT | -396.45% | -3,623.17% | -264.11% | -1,655.56% | |
| EBITDA | -481.92% | -1,408.26% | -261.11% | -6,860.15% | |
| EPS Basic | 20.43% | -11,427.78% | -222.47% | 86.20% | |
| Normalized Basic EPS | 2.50% | -5,868.18% | -220.64% | -207.96% | |
| EPS Diluted | 20.43% | -11,427.78% | 58.23% | 86.07% | |
| Normalized Diluted EPS | 2.50% | -5,868.18% | -220.64% | -207.96% | |
| Average Basic Shares Outstanding | 357.09% | 5.43% | 7.54% | 10.15% | |
| Average Diluted Shares Outstanding | 357.09% | 5.43% | 7.54% | 10.15% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |